• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Infigratinib-[13C4,15N2]

General Information
Catalog: BLP-014057
Molecular Formula: C22[13C]4H31Cl2N5[15N]2O3
Molecular Weight: 566.44
Chemical Structure
Infigratinib-[13C4,15N2]
Description Infigratinib-[13C4,15N2] is a labelled analogue of Infigratinib. Infigratinib is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities.
Synonyms 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl-2,3,5,6-[13C]4-1,4-[15N]2)phenyl)amino)pyrimidin-4-yl)-1-methylurea-[13C4,15N2]; NVPBGJ398-[13C4,15N2]; NVPBGJ 398-[13C4,15N2]
Related CAS 872511-34-7 (unlabelled)
Purity ≥99% atom 13C; ≥98% atom 15N

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket